Status:
COMPLETED
Mumbai Worksite Tobacco Control Study
Lead Sponsor:
Harvard School of Public Health (HSPH)
Collaborating Sponsors:
National Cancer Institute (NCI)
Healis-Sekhsaria Institute for Public Health
Conditions:
Tobacco Use Cessation
Eligibility:
All Genders
Phase:
NA
Brief Summary
The investigators are designing and testing the effectiveness of an integrated tobacco control and occupational health (OH) intervention aimed at promoting tobacco cessation among workers and supporti...
Detailed Description
Through 6 health education events at the worksites, blue-collar workers (who face dual health risks through their exposures to occupational hazards and their high rates of tobacco use) will gain the k...
Eligibility Criteria
Inclusion
- Manufacturing worksites located in the Mumbai, Thane, or Raigad districts of India
- Employ at least 60% production workers/40% administrative staff OR at employ at least 200 production workers on staff. NOTE: We are defining "workers" as anyone who is on the company roster, regardless of whether they're permanent or contractual
- Companies must be autonomous decision-makers and allow us to function at their worksite
- Companies must be willing to provide us with a current employee roster
Exclusion
- Employees do not speak English, Hindi, or Marathi
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2016
Estimated Enrollment :
6880 Patients enrolled
Trial Details
Trial ID
NCT01841879
Start Date
June 1 2010
End Date
June 30 2016
Last Update
April 17 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Healis-Sekhsaria Institute for Public Health
Navi Mumbai, Maharshtra, India